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Objectives. Theobjectiveofthis study was to evaluate the efkct 
of a transpulmottary contrast agent cm Doppler Row signals in the 
left heart chambers. 
Background. Echo contfest agents are geod ultrasound rettec- 
tars and could be used ar Doppler signal eobancen. Sunicawd 
alhumin mhrohubbles are transputmonary pchn ~wntra~t agents 
and could enhance left heart Doppler signals after paipheral 
wtous ittjeciiott. 
Me&d.r. Thirty-one patients with various heart diseases with. 
out intracardiac shunts aere assessed with Doppler Khoeardiog 
rapby befure and aft:: injection of sontcated albumin. 
Results. Ah an intravenous injection. pulsed Doppler signals 
of trnnrndtrat Bow bwame more iniense in all I6 patients exam- 
ined, although Row velocity i&elf was not changed. In Doppler 
color Bow imaging, the maximal s+ral regurgitant signal area 
The potential value of Doppler echocardiogrdphy has been 
widely recognized in clinical card;ology. It allows noninva- 
sive assessment of the physiology and aathophysiology of 
blood flow and calculation of intracardiac pressure gradients 
(I). The diagnostic sensitivity of the Doppler technique still 
depends in part on the quality of Doppler recordings. How- 
ever, Row detection may be difficult in certain patients 
because of increased absorption and scawering of sound 
waves by tissue between the transducer and the heart. To 
overcome this inherent limitation, a method of enhancing 
Doppler signal intensity would be desirable. 
Contrast echocardiography has ‘been usually rsed for 
visuFGng blood flow on two-dimensional echocardio- 
graphic imaging. Recently, several invesdgators have re- 
ported enhancement of trivial Doppler signals in the tight 
heart chambers after intravenous injection of contrast agents 
(2-6). This observation suggests that contrast agents could 
he used as Doppler signal enhancers. Among contrast 
agents, sotticatrd albumin microbubbles have been reported 
increased from 312 f 445 mm’ to 434 C 445 ram=, an average 
increaw of 59 * MQ in all 17 pat&s Hith OlitFnl ivgwgib& 
(p < 0.11). There effects were conridered to be due to improve 
ment of signal to noise ratio by the enhawettent of Du rtlow 
signals. The duratiw ufenhansement ofpu’kd fkppkr tram& 
ml Row signals was rijpdtieantty Ieager than that of tk l&t 
ventricular echocardiagraphk opacttteattea t&t i It s vs. 17 + 
7 f, p d 0.01). 
Conclusiotts. Intravenous i jection OF s&cat& albrmht can 
enhance the Daptkr Raw sigtmb in the :eft hear! c!a&ers. This 
effect mq he useful to improve the sensitivity of the Dopp?er 
system for detecting abnormalities of t&t heart blood flow such as 
mitral regurgitation. 
(.I Am C’ofl Car&l 19!23;21:737-42) 
to he capable of tmnspulmonary transmission and opacifica- 
tion of the left heart chambers after inttavettous icjeetion 
(7-10). If intravenous sonicated albumin microbubbles en- 
hance the left heart Doppter signals. enhancement of the 
diagnostic sensitivity of the Doppler system is possible. The 
purpose of this study is to examine the effect of intmvenous 
sonicaleC albumin on left heart Doppler Row signals. 
Methods 
Patients. The study group consisted of 31 patients with 
various heart diseases (ischemic hean disease in 15, valvttlar 
heart disease in 7, cardiomyopathy in 7. other disease in 2). 
There were 23 men and 8 women ranging in age from 33 to 81 
years (mean 57). All patients had sinus rhythm. This study 
was controlled by !:a Hospital Medical Ethics Committee 
and each patient gave informed consent. 
Contrast agent preparation. We used albumin nticrobnb- 
bles as lranspulmonary contrast agents (7,101. Albumin 
microbubbles were made by sonicaling albumin solution as 
reported previously (6). Briefly, 5 ml of 5% human serum 
albumin was sonicated with a commercially available soni- 
sating system (Sunitier 250. Branson Inc.) with a 3-mm 
titanium horn at 20 kHz and 20 W for 30 s. Immediately after 
sonication. 2 ml of the sonicated solution was inject-.: into 
an antecubital vein by way of a X-gauge needle and followed 
by a l&ml saline flush. 
JACC Vol. 21. No. 3 
March 1. 1993:737-41 
Figure 1. Pulsed Doppler recordings of 
transmitrat Row before (left panel) and 
after (right panel) sonicated albumin injec- 
tion. The intensity of the pulsed Doppler 
signals was increased after injection. The 
instantaneous mean velocity profile was 
not changed. EC0 = electrocardiogram; 
SV = sample volume. 
Contrast uhasound study. A combined two-dimensional 
and Doppler ultrasonograph using a 2.5 MHz transducer 
(Toshiba SSH-16OA) was used. Apical long-axis or four- 
chamber views were used to visualize let? heart chambers. 
Ultrasound recordings were obtained continuously before 
and after intravenous injection of sonicated albumin. Soni- 
cated albumin injection and ultrasound recordings were 
repeated three or four times in each patient leaving a lapse of 
at least IO min. All color Row images were recorded on a 
0.75 in. (1.9 cm) videotape (Sony). M-mode echocardio- 
grams and pulsed Doppler recordings were recorded on a 
strip chart recorder at a paper speed of 50 mm/s. The 
echocardiographic and Doppler gain control and filter set- 
tings were set as in routine clinical examinations and kept 
constant throughout each examination. 
The enhancing effect of albumin microbubbles on pulsed 
Doppler signal of the transmitral flow was evaluated by 
comparing flow signals before and after sottieated albumin 
injection in 16 patients. The effect on the Doppler color 
signal of mitral regurgitation was evaluated by comparing the 
maximal color signal area in 17 patients with mitral rzgurgi- 
tation before and after injection. Three still frame images of 
each measurement of color signal area were averaged. 
Reproducibility for this effect was assessed in IO randomly 
selected patients with mitral regurgitation. Interobserver 
variability was assessed in the same IO patients by two 
independent observers (A.T. and S.N.). The result was 
expressed as a linear regression between the two measttre- 
ments and as percent error that was derived as the absolute 
difference between measurements divided by the initial 
measurement. 
Further, to compare Ihe persistence of signal etthance- 
ment between Doppler and conventional echocardiography, 
the duration of transmitral flow signal e&:icement was 
compared with that of left ventricular contrast echo appear- 
ance in 10 patients. The duration of transmitral flrw signal 
enhancement was measured as the time during which the 
signal intensity was greater than the baseline intensity on a 
strip chart. The duration of the contrast echo appearance 
was measured as the time between appearance and disap 
parance of contrast trajectories seen on M-mode echocar- 
diogrdphy of the left ventricle from the apex. 
Analysis ofvelncity profile. To investjgate the mechanism 
of the enhancement of Doppler color signal after sonicatcd 
albumin injection, we compared velocity profiles along the 
short-axis of transmitral color flow in eight patients before 
and after sonicated albumin injection. The analysis of veloc- 
ity profile on the Doppler color display used a commercially 
available off-line echocardiographic viewing system consist- 
ing of a personal computer (model PC-9801, NEC) and a high 
speed image processor (Nexus 6810). This system enables 
the calculation of velocity born the color level on the video 
display and the presentation of the velocity profile on any 
line set on the display. 
Statistical analysis. Data were expressed as mean value * 
SD. Mitral regurgitant signal areas before and after injection 
were compared by using a Student paired I test. The same 
method was used to compare the duration of enhancement of 
transmitral flow signals and contrast echo in the left vetthi- 
cle. A p value < 0.05 was considered statistically significant. 
RHlltS 
Enhnaeen~~t of bppter sIgnA by sonic&d dhumin. In 
pulsed Doppler ret-rdings of transmitral flow, both the 
width and the intensity of the Doppler frequency spectrum 
were increased after sonicated albumin injection (Fig. 1). 
These effects were observed in all 16 patients examined. The 
instantaneous mean velocity profiles before and after soni- 
cated albumin injection were virlually identical. 
In Doppler color mode, right heart color flow signals were 
saturated soon after sonicated albumin injection, probably 
because of a strong reflection of sound by a lot of albumin 
microbubbles in the right heart chambers. After several 
seconds, the saturated signals disappeared and. thereafter, 
stable enhanced color Doppler signals were obtained in the 
left heart chambers. This enhancement effect was seen in all 
patients studied. Figure 2 shows the increass of mitral 
regurgitant Doppler color signal area after sonicated albumin 
injection. The maximal mitral regurgitant jet color signal 
area increased in all I7 patients with mitral regurgitation 
(312 + 405 mm2 to 434 + 465 mm’, p < 0.01) (Fig. 3). 
Reproducibility for this enhancing effect was good: the 
percent increase of mitr:! regurgitant area with albumin 
Figure 2. Apical Iongaxis view of 
mitral regurgitation before (left 
panel) and after trigh~ panel) soni- 
[ate< &bumin inWon. The mitral 
regurgitant jet igoal area was in- 
creased after conuast injection. 
LA = IcR atrium; LV = IeR vent& 
tie. 
microbubble injection was 74 + 36% far ihe fit;t injection 
and 72 -C 39% for the second injection (p = NS). The mean 
difference between the two measurements of oercent in- 
crease in each subiect was 6.4 + 6. I%. huerobserver corre- 
lation coefficients-were 0.998 and 0.9% and percent errors 
were 3.0 + 3.1% and 4.2 + 2.8% for the measuremcn~s 
before and after albumin micmbubble injection, respec- 
tively. 
Persistence of contrast etkt. The duration of enhance- 
ment of transmittal flow Doppler signals was 44 * II s. 
whereas the duration of the appearance of contrast echo in 
the left heart chambers was I7 k 7 s. Thus, the duration of 
enhancement of Doppler signal was significantly longer than 
that of contrast echo appearance (p < 0.01. Fig. 4). 
Figure 3. Mitral regurgitant jet area before and after sooicatcd 
albunun injection. The vcr(icnl tinny with P closed circle represent the 
mean value f I SD. 
Aualysb of veIncity pro& Figure 5 shows the analysis of 
the velocity profile beiore and after sonicated albumin 
injection along the shorl axis of transmittal Rcw. In the 
central arca of the flow, the displayed veIoc;ty estimates 
were almost the same before and after injection. However, 
in the marginal area of the flow. the displayed v&city 
estimates *#ere increased after sonicated albumin injection. 
indicating the augmentation of signal to noise ratio in the 
marginal area. This finding was consistent in all cases 
analyzed. 
Diussion 
Albumin micmhuhhk BS a haqmlmonary Doppler s&nal 
enhancer. Agents used for contrast echocardiography con- 
tain tiny suspended microbubbles or particles that scatter 
Figure 4. Comparison of the duration of let? heart opacifration and 
the pulsed Doppler enhancemeot. Echo = the duration of the 
appearance ofcontrast agents in Ihe left h-art chambers assessed by 
M-mode echocardiwmohv: Pulsed Drooler = the damlion of con- 
lmst enhancement 2 tkmival flow &cssed by pulsed Doppler 
echacardioenohv. The vcrtiepl tins witi~ a &cd ci& represent 
rhe mean v&v i I SD. 
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Fii5. Analysis oftransmitral flow 
velocity profile before (tell panel) and 
after Wght panel; sanicated albumin 
b&ion. The upper panels show that 
the color-coded area of transmittal 
flow was increased after injection. 
The lower panels show the velocity 
profiles along the short axis of trans. 
mitral Row (white line in upper pan- 
els). Thedisplayed velocity estimates 
were increased in the marginal area 
of the flow after injection. RA = right 
atrium; RV = right ventricle; other 
abbreviations as in Figure 2. 
Before After 
sound waves to a greater extent than the blood cells (I 1,lZ). 
Therefore, they could be used as Doppler signal enhancers 
as well as contrast echo agents. Indeed, several investigators 
have shown that the peripheral venous iiection of contrast 
agents could enhan’%e the Doppler signal of trivial tricuspid 
regurgitation (3-6). However. previom studies regarding 
enhancement of Doppler signal by contrast agents have been 
Iimitcd IO the right hean chambers. In this study we have 
shown that son&ted albumin microbubbles, which have 
been demonstrated as small as erythrocytes (I I) and used as 
transpulmonary contrast agents (7-10). enhanced the left 
heart Doppler flow signals. 
In pulsed Doppler mode. although the intensity of the 
Doppler signal was increibed, the displayed velocity was not 
affected by sonicated albumin injection. Analysis of the 
velocity profile in Doppler color mode also showed that peak 
velocity estimates were not altered before and afier injec- 
tion. This is because albumin microbubbles are moved only 
passively by the bloodstream at the same speed as red blood 
cells (1 I). 
Albt min microbubbles increased Doppler color signal 
areas, rl finding consistent with the recent in vitro study 
using several contrast agents (14). The increase in color 
signal area shouid not be ascribed 10 the increase in actual 
velocity of flow because albumin micrabubbles do not affect 
the Bow velocity. By analysis of velocity profile, we have 
shown that the increase in color signal area was due to the 
increase in disphy.4 velocity in the marginal area. The 
Figure ‘5. Possible mechanism of the increase in the color-coded 
signal area &or sonic&d albumin injection. Calculaied mean 
Doppler shifted frequency (f’d) is icss lhan the cutoff frequency 
Melted line) in Ihe marginal area of the blood Row (umr kft panel). 
Afler albumin microbubble injection, the calculated Doppler shifted 
frequency becomes larger than the cutoff frequency because of the 
increased power spechw of the Row signal W, resulting ia an 
increase in the cdor.ccded signal area (upper right paael). In the 
central area of the Row (lower puwls), the Row velocity is high 
before 8s well as afkr albumin microbubble iniection and ia little 
affecied by Ihe cutoff filter. Tlwefore. the Dop&r signal from Ihe 
blond flow is strong and Ihe e&et of clutter signals on the calcula- 
tion of mean Doppler shifted frequency is minimal. C = chaur 
signal: M = Doppler shifted frequency from blaod flow: P(fl = 
mechanism of this increase in displayed velocity is as follows 
(Fig. 6). In the marginal area of the flow, the flow velocity is 
low and is easily affected by the low cutoff lilrer. The clutter 
signal in that area is strong because the marginal area is near 
the cardiac wall. Thus, the displayed velocity estimate by 
Doppler color mode, which is calculated as :he mean of the 
Doppler shifted frequency from *he blood flow signal and 
clutter signal, is lower than the actual Row veiocity. In uiher 
words. low intensity signals in the marginal area arc misin- 
terpreted as noise by the low cutoff function. Therefore. the 
Doppler colcr signal in this area is not displayed. When the 
weak Doppler flow signals in the marginal arca are enhanced 
by albumin microbubbles, the signal IS littlc affected by the 
cutoff filter and the calculated mean frequency is increased, 
resulting in the increase of color display area. That i<. the 
signal intensity after enhancement is high enough to be 
above the threshold for Doppler color display. In contnst. in 
the central area of the Bow. the flow velocity is lngh and IS 
little affected by the cutoff filter before as well as after 
albumin microbubble injection. Therefore. the Doppler sig- 
nal from the blood Row in that apa is strong and the effect of 
clutter signals on the calculation of mean Doppler shifled 
frequency is minimal. 
Difference of contrspt elkt persistence between conven- 
tional and Doppler echocardlography. Persistence of Dopp- 
ler signal enhancement is significantly longer than echo 
contrast effect. This may be related to the fact that the 
sensitivity of Doppler echocardiography is superior to rhar 
of conventional echocardiography. Therefore, n smaller 
amount of sonic&d albumin may be needed with transpul- 
monary confrast Doppler technique than with conventional 
tnnspulmonary contrast echocardiography. Similar results 
using another contrast agent were reponed by Becher and 
Schlief (3). 
Clinical implications. To optimize poor Doppler record- 
ings, the Doppler gain control should be increased. How- 
ever. by increasing the gain control, noise Icvcls. as well as 
signal levels, increase. Sonic&d albumin increases signal 
levels without increasing noise levels and improves the 
signal to noise ratio not only in pulsed but also in Doppler 
color mode, thereby facilitating flow information in the left 
side of the heart when given intravenously. 
Doppler color signal area has been widely used to deter- 
mine the existence of valvular regurgitation clinicnlly (15). 
However, transthoracic Doppler color study is often limited 
by physical conditions such as obesity and emphysema. 
Contrast-enhanced Doppler technique improves the sensitiv- 
ity of Doppler color detection of flow nnd is useful to 
determine the existence of valvular regurgitation in paiienis 
with trace regurgitation or with poor Doppler recordmgs. 
Because Doppler color signal area is the result of many 
complex variables scch as jet facrors and technical and 
physical factors, the current Doppler color technique pm- 
vides only semiquantitative measurement and fails IO pro- 
vide a reliable and quantitative measurement of valvular 
regurgitation (15.16). Enhancement of Doppler color signal 
area with contrart agents might resolve the sensitivity proh- 
IemS and mltlga7.z some of these factors. Moreover. en- 
hanced Doppler color signal is helpful to position tbp pulsed 
or continuous wave Doppler beam to the center of flow of 
interest. enabling accurate determination of Row velocity. 
Limitations. We determined the duration of contrast 
echo appearance and Doppler signal enhancement subjec- 
tively by visual inspecrion on a strip chart. If an ohjecctive 
method such as analysis of the time-signal intensity ewe is 
applied 1171, our results would be strengthened. Although 
the Doppler color signal area of mitral regurgitarion was 
increased after sonicmed albumin injecrion, the degree of the 
mcreasr seemed not to be uniform among individual pa- 
tients. This finding might be due to hemodynamic diierences 
among parients. Cardiac output and ejection fraction would 
affect the transpulmonary passage of contrast agents. Pul- 
monary artery pressure has been reported to be a detenni- 
nant of IcR heart echocardiograpbic opacification (IS). More- 
over, the existence of tricuspid rcgorgitation would also 
nffect the tnnspulmonary passage of agents. Another cause 
of this variability may be the variability in size. concentra- 
tion and stability of albumin microbubbies. which causes 
variation in transpulmonary passage of albumin microbub- 
bles (71. Therefore, the mitral regurgitation signat area after 
sonicated albumin injection cannot be used for semiquaati- 
iativc grading of mitral regurgitation. More homogeneous 
microparticles such as Albunex might solve this problem 
(10). Doppler and conventional ecbocnrdiograpbic signal 
inrensiries are affected by the gnin control. Therefore, the 
duration of signal enhancement would be pmily dependent 
on the ulrrasound gain. In the present study, to avoid the 
possible effect of gain control on measurements. we set the 
Doppler and conventional echocardiagraphic gal:1 optimally 
as in routine examinations and kept conjtant during the 
study. 
Conclusions. Peripheral vennus injection of sonicated 
albumin enhanced the Doppler flow signals in the left heart 
chambers. The transpulmonary contrast-enhanced Doppler 
technique is useful to increase the sensitivity of the Doppler 
syslem for obtaining Row information in the left heart 
chambers. 
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